Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter A Fasching

Showing results (51-60 of 810) with videos related to

Pageof 81
Sort By:
Breast Cancer Research and Treatment|June 29, 2018
The effect of participation in neoadjuvant clinical trials on outcomes in patients with early breast cancerMeghan Brennan, Paul Gass, Lothar Häberle, et al.
Breast Care (Basel, Switzerland)|May 24, 2012
Cost-Benefit Analysis of Endocrine Therapy in the Adjuvant Setting for Postmenopausal Patients with Hormone Receptor-Positive Breast Cancer, Based on Survival Data and Future Prices for Generic Drugs in the Context of the German Health Care SystemMichael P Lux, Claudia Reichelt, Jon Karnon, et al.
Cancer Biology & Therapy|February 1, 2011
Expression and localization of the uptake transporters OATP2B1, OATP3A1 and OATP5A1 in non-malignant and malignant breast tissueJuergen Kindla, Tilman T Rau, Rudolf Jung, et al.
International Journal of Cancer|September 25, 2008
Early aberrant insulin-like growth factor signaling in the progression to endometrial carcinoma is augmented by tamoxifenPamela L Strissel, Stephan Ellmann, Elke Loprich, et al.
Oncology and Therapy|November 14, 2025
Investigating Real-World Evidence and Reported Survival Outcomes of CDK4/6 Inhibitors in HR+/HER2- Advanced Breast CancerSarah Sammons, Denise A Yardley, Priyanka Sharma, et al.
Expert Review of Molecular Diagnostics|June 5, 2003
Aspects of molecular diagnostics and therapy in obstetrics and gynecologyMatthias W Beckmann, Reiner Strick, Pamela L Strissel, et al.
Future Oncology (London, England)|August 21, 2023
Association between event-free survival and overall survival in early-stage triple-negative breast cancerMin Huang, Peter A Fasching, Amin Haiderali, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|December 12, 2023
Fetal Re-Identification in Multiple Pregnancy Ultrasound Images Using Deep LearningElisabeth Gabler, Michael Nissen, Thomas R Altstidl, et al.
Pharmaceuticals (Basel, Switzerland)|March 28, 2026
Physiologically-Based Pharmacokinetics of Ribociclib Drug-Drug Interactions and Organ Impairment Pharmacokinetics in Early Breast CancerYan Ji, Felix Huth, Craig Wang, et al.
European Journal of Cancer (Oxford, England : 1990)|November 2, 2022
Q-TWiST analysis of pembrolizumab combined with chemotherapy as first-line treatment of metastatic triple-negative breast cancer that expresses PD-L1Min Huang, Joyce O'Shaughnessy, Amin Haiderali, et al.
Pageof 81

Showing results (51-60 of 810) with videos related to

Sort By:
Pageof 81
Breast Cancer Research and Treatment|June 29, 2018
The effect of participation in neoadjuvant clinical trials on outcomes in patients with early breast cancerMeghan Brennan, Paul Gass, Lothar Häberle, et al.
Breast Care (Basel, Switzerland)|May 24, 2012
Cost-Benefit Analysis of Endocrine Therapy in the Adjuvant Setting for Postmenopausal Patients with Hormone Receptor-Positive Breast Cancer, Based on Survival Data and Future Prices for Generic Drugs in the Context of the German Health Care SystemMichael P Lux, Claudia Reichelt, Jon Karnon, et al.
Cancer Biology & Therapy|February 1, 2011
Expression and localization of the uptake transporters OATP2B1, OATP3A1 and OATP5A1 in non-malignant and malignant breast tissueJuergen Kindla, Tilman T Rau, Rudolf Jung, et al.
International Journal of Cancer|September 25, 2008
Early aberrant insulin-like growth factor signaling in the progression to endometrial carcinoma is augmented by tamoxifenPamela L Strissel, Stephan Ellmann, Elke Loprich, et al.
Oncology and Therapy|November 14, 2025
Investigating Real-World Evidence and Reported Survival Outcomes of CDK4/6 Inhibitors in HR+/HER2- Advanced Breast CancerSarah Sammons, Denise A Yardley, Priyanka Sharma, et al.
Expert Review of Molecular Diagnostics|June 5, 2003
Aspects of molecular diagnostics and therapy in obstetrics and gynecologyMatthias W Beckmann, Reiner Strick, Pamela L Strissel, et al.
Future Oncology (London, England)|August 21, 2023
Association between event-free survival and overall survival in early-stage triple-negative breast cancerMin Huang, Peter A Fasching, Amin Haiderali, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|December 12, 2023
Fetal Re-Identification in Multiple Pregnancy Ultrasound Images Using Deep LearningElisabeth Gabler, Michael Nissen, Thomas R Altstidl, et al.
Pharmaceuticals (Basel, Switzerland)|March 28, 2026
Physiologically-Based Pharmacokinetics of Ribociclib Drug-Drug Interactions and Organ Impairment Pharmacokinetics in Early Breast CancerYan Ji, Felix Huth, Craig Wang, et al.
European Journal of Cancer (Oxford, England : 1990)|November 2, 2022
Q-TWiST analysis of pembrolizumab combined with chemotherapy as first-line treatment of metastatic triple-negative breast cancer that expresses PD-L1Min Huang, Joyce O'Shaughnessy, Amin Haiderali, et al.
Pageof 81